Target delivery of photo-triggered nanocarrier for externally activated chemo-photodynamic therapy of prostate cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Advances in highly doped upconversion nanoparticles10.1038/s41467-018-04813-5 ↗
2. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment10.1186/s12951-019-0560-5 ↗
3. (α-NaYbF4: Tm3+)/CaF2 core/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging10.1021/nn302972r ↗
4. Monodisperse nanocrystals: general synthesis, assembly, and their applications10.1039/b700183e ↗
5. Water-soluble NaYF4: Yb, Er (Tm)/NaYF4/polymer core/shell/shell nanoparticles with significant enhancement of upconversion fluorescence10.1021/cm062447y ↗
6. Trypsin mediated one-pot reaction for the synthesis of red fluorescent gold nanoclusters: sensing of multiple analytes (carbidopa, dopamine, Cu2+, Co2+ and Hg2+ ions), Spectrochim
7. Versatile synthesis strategy for carboxylic acid−functionalized upconverting nanophosphors as biological labels10.1021/ja076151k ↗
8. NIR-responsive silica-coated NaYbF4: Er/Tm/Ho upconversion fluorescent nanoparticles with tunable emission colors and their applications in immunolabeling and fluorescent imaging of cancer cells10.1021/jp906394z ↗
9. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
10. Imaging-guided pH-sensitive photodynamic therapy using charge reversible upconversion nanoparticles under near-infrared light10.1002/adfm.201202992 ↗
11. In vitro and in vivo uncaging and bioluminescence imaging 441 by using photocaged upconversion nanoparticles10.1002/ange.201107919 ↗
12. Responsive assembly of upconversion nanoparticles for pH-activated and near_infrared-triggered photodynamic therapy of deep tumors10.1002/adma.201802808 ↗
13. Multifunctional upconversion–nanoparticles–trismethylpyridylporphyrin fullerene nanocomposite: a near-infrared light-triggered theranostic platform for imaging-guided photodynamic therapy10.1038/am.2015.82 ↗
14. Amplifying the red-emission of upconverting nanoparticles for biocompatible clinically used prodrug-induced photodynamic therapy10.1021/nn505051d ↗
15. Metal–organic framework-based stimuli-responsive systems for drug delivery10.1002/advs.201801526 ↗
16. Recent research and progress of biodegradable zinc alloys and composites for biomedical applications: biomechanical and biocorrosion perspectives
17. Fabrication of functional hollow microspheres constructed from MOF shells: promising drug delivery systems with high loading capacity and targeted transport10.1038/srep37705 ↗
18. Advances in PSMA-targeted therapy for prostate cancer
19. Cancer statistics, 2016
20. Integrin-targeted peptide-and peptidomimetic-drug conjugates for the treatment of tumors, Recent Patents on Recent Pat
21. Combination prostate cancer therapy: prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone10.1080/10717544.2021.1931559 ↗
22. Sipuleucel-T immunotherapy for castration-resistant prostate cancer10.1056/NEJMoa1001294 ↗
23. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial10.1016/S0140-6736(10)61389-X ↗
24. Abiraterone and increased survival in metastatic prostate cancer10.1056/NEJMoa1014618 ↗
25. Enzalutamide in metastatic prostate cancer before chemotherapy10.1056/NEJMoa1405095 ↗
26. Alpha emitter radium-223 and survival in metastatic prostate cancer10.1056/NEJMoa1213755 ↗
27. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?10.1016/S0065-2571(97)00015-0 ↗
28. PSMA-targeted theranostic nanocarrier for prostate cancer10.7150/thno.18879 ↗
29. Development of targeted near-infrared imaging agents for prostate cancer10.1158/1535-7163.MCT-14-0422 ↗
30. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
31. Heterogeneous PSMA expression on circulating tumor cells-a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer10.18632/oncotarget.9004 ↗
32. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate10.1039/b927215c ↗
33. One-pot synthesis of carbon dots with intrinsic folic acid for synergistic imaging-guided photothermal therapy of prostate cancer cells10.1039/C9BM01228A ↗
34. Preparation & structural investigations of Copper (II), Cobalt (II), Nickel (II) & Zinc (II) derivatives of 2, 9, 16, 23-phthalocyanine tetracarboxylic acid
35. Reconstructing the intracellular pH microenvironment for enhancing photodynamic therapy10.1039/C9MH01824G ↗
36. Tunable near infrared to ultraviolet upconversion luminescence enhancement in (α-NaYF4: Yb, Tm)/CaF2 Core/Shell nanoparticles for in situ real-time recorded biocompatible photoactivation10.1002/smll.201300234 ↗
37. NIR-to-NIR two-photon excited CaF2: Tm3+, Yb3+ nanoparticles: multifunctional nanoprobes for highly penetrating fluorescence bio-imaging10.1021/nn202490m ↗
38. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals10.1039/b809132n ↗
39. A pH-activable chemo–photodynamic therapy based on cube-wrapped-cube α-NaYbF4: Tm@ CaF2/Nd@ ZnO nanoparticles mediated by 808 nm light10.1021/acs.chemmater.0c02624 ↗
40. 1H NMR spectra part 31: 1H chemical shifts of amides in DMSO solvent10.1002/mrc.4079 ↗
41. Photo-induced reactions for disassembling of coloaded photosensitizer and drug molecules from upconversion-mesoporous silica nanoparticles: an effective synergistic cancer therapy10.1016/j.msec.2019.110545 ↗
42. ZnO–DOX@ ZIF-8 core–shell nanoparticles for pH-responsive drug delivery10.1021/acsbiomaterials.7b00435 ↗
43. ZIF-8 as a promising drug delivery system for benznidazole: development, characterization, in vitro dialysis release and cytotoxicity10.1038/s41598-020-73848-w ↗
44. pH-triggered degradation and release of doxorubicin from zeolitic imidazolate framework-8 (ZIF8) decorated with polyacrylic acid10.1039/D0RA10423J ↗
45. Degradation of ZIF-8 in phosphate buffered saline media10.1039/C9CE00757A ↗
46. Engineering of upconverted metal–organic frameworks for near-infrared light-triggered combinational photodynamic/chemo-/immunotherapy against hypoxic tumors10.1021/jacs.9b12788 ↗
47. Recent advances of upconversion nanoparticles in theranostics and bioimaging applications10.1016/j.trac.2019.115646 ↗
48. Current use of PSMA–PET in prostate cancer management10.1038/nrurol.2016.26 ↗
49. Polymer-coated NaYF4: Yb3+, Er3+ upconversion nanoparticles for charge-dependent cellular imaging10.1021/nn201896m ↗
50. Engineering chimeric receptors to investigate the size-and rigidity-dependent interaction of PEGylated nanoparticles with cells10.1021/acsnano.5b05661 ↗
51. Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells10.1038/s41565-020-0643-3 ↗
52. A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma10.1039/D1TB01136G ↗
53. Doxorubicin pathways: pharmacodynamics and adverse effects10.1097/FPC.0b013e32833ffb56 ↗
54. Grass-mediated biogenic synthesis of silver nanoparticles and their drug delivery evaluation: a biocompatible anti-cancer therapy10.1016/j.cej.2020.127202 ↗